Research article
Long-term prognosis of breast cancer detected by mammography screening or other methods
-
* Corresponding author: Tiina Lehtimäki tiina.lehtimaki@helsinki.fi
1 Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Biomedicum Helsinki 2U, Tukholmankatu 8, PO Box 20, FI-00014 Helsinki, Finland
2 Molecular Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, Tukholmankatu 8, PO Box 20, FI-00014, Helsinki, Finland
3 Departments of Palliative Medicine and Oncology, Tampere University Hospital and University of Tampere, Teiskontie 35, PO Box 2000, FI-33521,Tampere, Finland
4 Department of Oncology and Hematology, Oulu University Central Hospital, Kajaanintie 50, PO Box 20, FI-90029, Oulu, Finland
5 Cancer Center, Kuopio University Central Hospital, Puijonlaaksontie 2, PO Box 1777, FI-70211, Kuopio, Finland
6 Institute of Medical Technology, University of Tampere and Tampere University Hospital, Biokatu 8-12, PO Box 2000, FI-33520,Tampere, Finland
7 Department of Oncology, Helsinki University Central Hospital, Haartmaninkatu 4, PO Box 180, FI-00029, Helsinki, Finland
8 Division of Global Health, Karolinska Institutet, SE-17177, Stockholm, Sweden
Breast Cancer Research 2011, 13:R134 doi:10.1186/bcr3080
Published: 28 December 2011Additional files
Additional file 1:
Consort diagrams for main analyses, the first sensitivity analyses and the second sensitivity analyses.
Format: XLSX Size: 16KB Download file
Additional file 2:
Table S1 Distribution of breast cancers in the FinProg data according to the method of measurement and the method of detection (exclusions according to main analyses, N = 1,884). Table S2 Adjustment according to tumor size after analyzing proportion of different grades in screen-detected and non-screen-detected patients (exclusions according to main analyses, N = 1,884).
Format: DOCX Size: 15KB Download file